By: Benzinga
Acadia Pharma Rockets Higher on Study Results
Shares of Acadia Pharma (NASDAQ: ACAD ) surged higher on Tuesday, after the company said its antipsychotic drug showed positive results in patients with Parkinson's. Anyone holding shares of Acadia greatly benefitted, as the biotech more than doubled -- up over 140 percent at one point. The study met its primary
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here